A recent study has reported on a multiple sclerosis (MS) patient who developed pulmonary sarcoidosis after receiving the relapsing-remitting MS (RRMS) therapy daclizumab. The report “Pulmonary Sarcoidosis in a patient with Multiple Sclerosis on daclizumab monotherapy,” was published in Multiple Sclerosis and Related Disorders. Daclizumab is a…
Search results for:
Blood levels of a soluble protein can be used as a diagnostic test to confirm sarcoidosis in cases of acute uveitis, a test that is superior to the standard biomarker used, called angiotensin-converting enzyme (ACE). The results were reported in “Diagnostic…
Large-Scale Study Reinforces the Importance of Detecting, Preventing Heart Disease in Sarcoidosis
The number of hospitalizations of sarcoidosis’ patients in the U.S. has increased over the past decade with more than one-third showing heart-related disorders, according to a study published in the Journal of the American Heart Association. Moreover, sarcoidosis hospitalizations are more frequent in urban as compared with rural hospitals, blacks…
The first patient was recently enrolled in a Phase 4 trial to further evaluate the effectiveness of H.P. Acthar Gel as a therapy for pulmonary sarcoidosis, according to Mallinckrodt. Acthar Gel (repository corticotropin injection) is a U.S. Food and Drug Administration (FDA)-approved therapy for 19 different indications, including respiratory symptomatic…
Extrathoracic Disease More Prevalent in WTC Firefighters with Sarcoidosis Post-9/11, Study Finds
A recent observational study showed that extrathoracic disease has a high incidence in World Trade Center firefighters who developed sarcoidosis following the 9/11 attack in the United States. The study, “Clinical Course of Sarcoidosis in World Trade Center-Exposed Firefighters,” was published in the journal Chest. Last…
Scientists at the University of Manchester in England will look into the cause of sarcoidosis with the help of a £120,000 pound (about $166,750 U.S.) research funding grant awarded by the British Lung Foundation and SarcoidosisUK as part of a long-term commitment to finding a cure for the…
A new case report describes a sarcoidosis patient with pancreatitis — inflammation of the pancreas — and hypercalcemia, or high calcium levels. The study, “Hypercalcemic pancreatitis a rare presentation of sarcoidosis: A case report,” was published in the journal Medicine. Sarcoidosis is a complex disease with…
Researchers are developing a new positron emission tomography (PET) scanner capable of imaging the whole body that promises to significantly increase imaging sensitivity, advancing the technology for how diseases such as sarcoidosis are diagnosed and treated. “It will offer the ability to detect throughout the whole body the location of…
The World Association for Sarcoidosis and Other Granulomatous Disorders (WASOG) and the Foundation for Sarcoidosis Research (FSR) have designated Temple Lung Center’s specialized sarcoidosis program as an official WASOG Sarcoidosis Clinic, one of only 27 such designations in the world. The WASOG Sarcoidosis Clinic designation recently…
Male Sarcoidosis Patients, Those on Immunosuppressive Agents Face Higher Risk for Severe Infections
Male sarcoidosis patients and those who use immunosuppressive agents — particularly Cytoxan (cyclophosphamide) — are more likely to get severe infections than women with the disease and those who don’t take such medications, a French study suggests. The study “Severe infections in sarcoidosis: Incidence, predictors and long-term outcome in a cohort of…